DEFA14A: SELLAS Life Sciences Updates Proxy Statement Following Auditor Merger, Confirms 'Going Concern' Note

SELLAS Life Sciences Group, Inc. has issued a supplement to its 2025 Annual Meeting proxy statement, announcing the appointment of Baker Tilly US, LLP as its new independent auditor following a merger involving its previous auditor, Moss Adams LLP, while also noting a 'going concern uncertainty' in past financial statements.

Summary

• SELLAS Life Sciences Group, Inc. filed Supplement No. 1 to its definitive proxy statement for the 2025 Annual Meeting of Stockholders.
• The supplement addresses the merger of the Company's independent registered public accounting firm, Moss Adams LLP, with Baker Tilly US, LLP on June 3, 2025.
• Following the merger, Moss Adams LLP resigned, and the Company's Audit Committee approved the appointment of Baker Tilly US, LLP as the successor auditor for the fiscal year ending December 31, 2025.
• Moss Adams's audit report on the Company's consolidated financial statements for the years ended December 31, 2024 and 2023, included an explanatory paragraph regarding a 'going concern uncertainty'.
• There were no disagreements or reportable events with Moss Adams during the fiscal years 2023, 2024, or the subsequent interim period.
• Proposal 2 in the original Proxy Statement, which sought ratification of Moss Adams, will now be treated as a vote for the ratification of Baker Tilly as the successor accounting firm.
• Stockholders who have already submitted proxy cards or voting instructions do not need to resubmit them unless they wish to change their vote, as existing instructions remain valid for the updated Proposal 2.

Sentiment

Score: 4

Explanation: While the auditor transition is an administrative matter handled smoothly, the explicit mention of a 'going concern uncertainty' in the previous audit report for 2023 and 2024 is a significant negative financial indicator, outweighing the administrative positives.

Positives

• The transition of the independent registered public accounting firm was smooth, resulting from a merger rather than a dispute or performance issue.
• Moss Adams's audit report did not contain an adverse opinion or a disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope, or accounting principles (aside from the going concern explanatory paragraph).
• There were no disagreements or reportable events with Moss Adams during the fiscal years 2023, 2024, and the subsequent interim period, indicating a clean relationship with the former auditor.

Negatives

• Moss Adams's audit report on the Company's consolidated financial statements for the fiscal years ended December 31, 2024 and 2023, contained an explanatory paragraph regarding a 'going concern uncertainty', indicating potential doubts about the Company's ability to continue as a going concern.

Risks

• The primary risk highlighted is the 'going concern uncertainty' noted in the audit report for fiscal years ended December 31, 2024 and 2023, which suggests significant doubt about the Company's ability to continue operations without further financing or other mitigating actions.

Future Outlook

The document primarily addresses an administrative change regarding the Company's independent auditor for the fiscal year ending December 31, 2025, and does not provide specific forward-looking financial guidance or strategic outlook beyond this appointment.

Management Comments

• The Company intends to treat Proposal 2 of the Proxy Statement as a ratification of the appointment by the Audit Committee of Baker Tilly, as the successor to Moss Adams, as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.
• The Company notes that it will not make available or distribute new proxy cards or require new voting instructions, and previously submitted proxy cards or voting instructions will remain valid.

Industry Context

The merger of accounting firms is a common occurrence in the professional services industry, leading to administrative changes for their clients. For a life sciences company like SELLAS, the continuity of audit services is crucial for regulatory compliance and investor confidence, although the underlying 'going concern' issue remains a company-specific financial challenge.

Corporate Governance

Stakeholder Impact

• Shareholders: Directly impacted by the updated voting instructions for Proposal 2 at the Annual Meeting and the underlying financial health implications of the 'going concern' note.
• Investors: The 'going concern uncertainty' is a critical piece of information for current and prospective investors assessing the Company's financial viability.

Next Steps

• Stockholders are urged to vote on Proposal 2 (ratification of Baker Tilly as the independent auditor) for the 2025 fiscal year.
• The 2025 Annual Meeting of Stockholders is scheduled for June 17, 2025.

Key Dates

Recommendation

Keywords

SELLAS Life Sciences, SEC filing, DEFA14A, proxy statement, auditor change, Baker Tilly, Moss Adams, corporate governance, annual meeting, going concern, financial reporting, biotechnology, pharmaceuticals